PROTALIX BIOTHERAPEUTICS INC

Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROTALIX BIOTHERAPEUTICS INC NOTE 4.500% 9/1, CUSIP 74365AAB7.